Consolidated Condensed Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating activities:
Net earnings	$ 43,608	$ 36,249
Adjustments to reconcile net earnings to net cash provided by operations:
Depreciation	8,619	9,132
Amortization	12,358	9,803
Deferred income taxes	42	401
Noncurrent employee benefits	232	571
Stock-based compensation expense	1,537	1,041
Changes in:
Receivables	(8,985)	3,184
Inventories	(5,685)	5,188
Payables	7,420	(2,175)
Prepaid expenses and other assets	(9,321)	6,485
Other liabilities	12,935	3,799
Total adjustments	19,152	37,429
Net cash provided by operations	62,760	73,678
Investing activities:
Property, plant and equipment expenditures	(8,169)	(5,855)
Proceeds from company owned life insurance plans	596
Acquisitions, net of cash acquired	(45,273)
Net cash used for investing activities	(52,846)	(5,855)
Financing activities:
Net decrease short-term debt		(4,600)
Dividends paid	(16,318)	(15,108)
Proceeds from exercise of stock options	2,037	505
Repurchase of treasury stock	(460)	(2,934)
Issuance of treasury stock	72	126
Net cash used for financing activities	(14,669)	(22,011)
Effect of foreign exchange rates on cash	(480)	(782)
(Decrease) Increase in cash and cash equivalents	(5,235)	45,030
Cash and cash equivalents – beginning of period	72,273	48,871
Cash and cash equivalents – end of period	$ 67,038	$ 93,901